A Study to Evaluate Relative Bioavailability, Proton Pump Inhibitor (PPI) (Rabeprazole) Effect, Food Effect and Particle Size Effect of New Acalabrutinib Tablet in Healthy Subjects
Clinical trial NCT04488016 · COMPLETED
Trial details
- NCT number
- NCT04488016
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-24
- Primary completion
- 2021-01-20
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.